Prostaglandins support menstruation by tightening uterine muscles and blood vessels. However, the high prostaglandin levels around the start of your period cause cramps. Secondary dysmenorrhea: ...

Copper IUDs (intrauterine devices) are a safe and effective type of birth control. It works by preventing sperm from fertilizing any eggs. Learn more about how to determine whether it’s right ...

Intrauterine devices (IUDs) are one of the most effective and low-maintenance forms of birth control available, with a failure rate of less than 1% per year. They prevent pregnancy by either releasing ...

本文来自：华尔街见闻，作者：张雅琦，原文标题：《近两年来最大生物技术并购！强生百亿收购Intra-Cellular，后者盘前飙升近38%》 强生收购Intra-Cellular，将目光瞄准中枢神经系统疾病市场。 1月13日，强生公司以146亿美元收购Intra-Cellular Therapies，以增强其在神经 ...

The purchase will allow Johnson & Johnson to delve further into the treatment of central nervous system disorders. The purchase is one of several transactions in recent years to boost its ...

Johnson & Johnson (NYSE:JNJ) announced a $14.6 billion acquisition of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) ahead of this week’s JP Morgan Healthcare Conference. Shares of Intra-Cellular ...

Copyright 2025 The Associated Press. All Rights Reserved. The Johnson & Johnson headquarters in New Brunswick, New Jersey, on Feb. 8, 2024. (AP Photo/Ted Shaffrey ...

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Johnson & Johnson is in talks to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said. A ...

(RTTNews) - Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...